期刊文献+

真性红细胞增多症与原发性血小板增多症的实验室检查特征 被引量:5

下载PDF
导出
摘要 目的根据2008年WHO诊断标准,分析真性红细胞增多症(PV)与原发性血小板增多症(ET)患者的实验室检查特征。方法回顾性分析114例PV、ET初诊患者血液、骨髓涂片、骨髓病理组织学及JAK2V617F基因检测结果。结果与ET患者相比,PV患者WBC和Hb水平增高(P<0.05),PLT下降(P<0.05),红细胞系百分数增高(P<0.05)。与JAK2V617F基因阴性PV患者相比,JAK2V617F基因阳性PV患者WBC、PLT明显增高(P<0.05),粒细胞系、粒/红比值、巨核细胞计数增高(P<0.05)。JAK2V617F基因阳性ET患者骨髓活检多见三系增生,未见骨髓纤维化。结论 PV、ET患者及JAK2V617F基因阳性或阴性的PV、ET患者实验室检查特征不同,对指导临床诊断具有一定意义。
出处 《临床检验杂志》 CAS CSCD 北大核心 2013年第4期310-312,共3页 Chinese Journal of Clinical Laboratory Science
  • 相关文献

参考文献13

  • 1Tefferi A, Vardiman JW. Classification and diagnosis of myeloprolifer- ative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms [ J ]. Leukemia, 2008, 22 ( 1 ) : 14-22.
  • 2Campbell PJ, Scott LM, Buck G, et al. Definition of subtypes of es- sential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status : a prospective study [ J ]. Lancet, 2005, 366(9501 ) :1945-1953.
  • 3Antonioli E, Guglielmelli P, Pancraszi A. Clinical implications of the JAK2 V617F mutation in essential thrombocytbemia [ J ]. Leuke- mia, 2005,19 (10) : 1847-1849.
  • 4Wolanskyj AP, Lasho TL, Sehwager SM, et al. JAK2 mutation in es- sential thrombocythaemia: clinical associations and long-term prog- nostic relevance [ J ]. Br J Haematol, 2005, 131 (2) :208-213.
  • 5Swerdlow SH, Campo E, Harris NL, et al. (2008) World Health Organization classification of tumours of haematopoietic and lymphoid tissues[ M]. IARC, Lyon, 2008:40-49.
  • 6Spivak JL. Narrative review : thrombocytosis, polycythemia vera, and JAK2 mutations : the phenotypic mimicry of chronic myeloproliferation [J]. Ann Intern Med, 2010, 152(5) :300-306.
  • 7Wadleigh M, Tefferi A. Classification and diagnosis of myeloprolifer- ative neoplasms according to the 2008 World Health Organization cri- teria[J]. Int J Hematol, 2010, 91 (2) :174-179.
  • 8Thiele J, Kvasnicka HM, Vardiman J. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl[J]. Best Pract Res Clin Haematol, 2006,19(3) :413-437.
  • 9Thiele J, Kvasnicka HM. Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disorders [ J]. Semin Thromb Hemost, 2006,32 (3) :219-230.
  • 10Lippert E, Boissinot M, Kralovics R, et al. The JAK2-V617F muta- tion is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera[ J ]. Blood ,2006,108 (6) : 1865-1867.

二级参考文献14

  • 1宋君红,李建勇,张苏江.骨髓增殖性疾病JAK2基因V617F点突变研究[J].中华血液学杂志,2006,27(9):632-633. 被引量:18
  • 2宋君红,张苏江,李建勇.JAK2基因突变与慢性骨髓增殖性疾病[J].中华血液学杂志,2006,27(10):713-715. 被引量:7
  • 3陆米则,李建勇,段丽敏,潘金兰,仇海荣,沈云峰,薛永权.原发性血小板增多症的细胞遗传学特征[J].实用临床医药杂志,2006,10(5):25-27. 被引量:3
  • 4段丽敏,李建勇,潘金兰,仇海荣,张苏江,吴亚芳,徐卫,薛永权.真性红细胞增多症的细胞遗传学研究[J].中国实验血液学杂志,2007,15(1):121-124. 被引量:10
  • 5李伟达,李建勇,张苏江,仇海荣,徐卫,王季石.特发性骨髓纤维化患者JAK2V617F突变研究[J].中国实验血液学杂志,2007,15(2):387-390. 被引量:10
  • 6Baxter E J, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase jak2 in human myeloproliferative disorders. Lancet, 2005 ;365(9464) :1054 - 1061
  • 7James C, Ugo V, Le-Couedic JP, et al. A unique clonal jak2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 2005 ;434 ( 3037 ) : 1144 - 1148
  • 8Wernig G, Mercher T, Okabe R, et al. Expression of jak2v617f causes a polycythemia vera like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood, 2006;107:4274 -4281
  • 9Speletas M, Katodritou E, Daiou C, et al. Correlations of jak2- V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders. Leuk Res, 2007 ; 31 : 1053 - 1062
  • 10Antonioli E, Guglielmelli P, Pancrazzi A, et al. Clinical implicaions of the jak2v617f mutation in primary thrombocythaemia. Leukemia, 2005 ; 19 : 1847 - 1849

共引文献14

同被引文献16

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部